Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT



Hykin, Philip, Prevost, A Toby, Sivaprasad, Sobha, Vasconcelos, Joana C, Murphy, Caroline, Kelly, Joanna, Ramu, Jayashree, Alshreef, Abualbishr, Flight, Laura, Pennington, Rebekah
et al (show 9 more authors) (2021) Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. HEALTH TECHNOLOGY ASSESSMENT, 25 (38). 1 - +.

[img] Text
HykinNIHRReport2021.pdf - OA Published Version

Download (4MB) | Preview
Item Type: Article
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 09 Aug 2021 09:44
Last Modified: 10 Sep 2022 07:58
DOI: 10.3310/hta25380
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3132896